Loading
Latest filing published 15 Apr 2026 for Marinomed Biotech AG, €4,998.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Andreas Grassauer is a declared insider of Marinomed Biotech AG (board member), with filings sourced from FMA (OeKB OAM). We count 3 filings; the first trade dates from 31 March 2026 and the latest from 13 April 2026.
The open-market record is one-sided, with 1 purchase worth €4,998 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 15 April 2026, the filings show an open-market purchase worth €4,998 in Marinomed Biotech AG. Publication is fast: at least half of the trades appear on FMA (OeKB OAM) on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by FMA (OeKB OAM) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations